Your browser doesn't support javascript.
loading
Side effects that occurred early in people with multiple sclerosis during the first year of treatment with cladribine tablets: a plain language summary.
Oh, Jiwon; Walker, Bryan; Giovannoni, Gavin; Jack, Dominic; Dangond, Fernando; Nolting, Axel; Aldridge, Julie; Lebson, Lori A; Leist, Thomas P.
Afiliação
  • Oh J; Division of Neurology, Department of Medicine, St Michael's Hospital, University of Toronto, Toronto, Canada.
  • Walker B; Department of Neurology, Duke University School of Medicine, Durham, NC, USA.
  • Giovannoni G; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Jack D; Merck Serono Ltd., Feltham, UK, an affiliate of Merck KGaA.
  • Dangond F; EMD Serono Research and Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA.
  • Nolting A; Merck Healthcare KGaA, Darmstadt, Germany.
  • Aldridge J; EMD Serono Research and Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA.
  • Lebson LA; EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA.
  • Leist TP; Comprehensive Multiple Sclerosis Center, Jefferson University, Philadelphia, PA, USA.
Neurodegener Dis Manag ; 12(1): 1-7, 2022 02 01.
Article em En | MEDLINE | ID: mdl-35019731
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cladribina / Esclerose Múltipla Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cladribina / Esclerose Múltipla Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article